Academic Journal

Decoding the metastatic potential and optimal postoperative adjuvant therapy of melanoma based on metastasis score

التفاصيل البيبلوغرافية
العنوان: Decoding the metastatic potential and optimal postoperative adjuvant therapy of melanoma based on metastasis score
المؤلفون: Kangjie Shen, Wenyu Song, Hongye Wang, Lu Wang, Yang Yang, Qianrong Hu, Min Ren, Zixu Gao, Qiangcheng Wang, Shaoluan Zheng, Ming Zhu, Yanwen Yang, Yong Zhang, Chuanyuan Wei, Jianying Gu
المصدر: Cell Death Discovery, Vol 9, Iss 1, Pp 1-14 (2023)
بيانات النشر: Nature Publishing Group, 2023.
سنة النشر: 2023
المجموعة: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC:Cytology
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Cytology, QH573-671
الوصف: Abstract Metastasis is a formidable challenge in the prognosis of melanoma. Accurately predicting the metastatic potential of non-metastatic melanoma (NMM) and determining effective postoperative adjuvant treatments for inhibiting metastasis remain uncertain. In this study, we conducted comprehensive analyses of melanoma metastases using bulk and single-cell RNA sequencing data, enabling the construction of a metastasis score (MET score) through diverse machine-learning algorithms. The reliability and robustness of the MET score were validated using various in vitro assays and in vivo models. Our findings revealed a distinct molecular landscape in metastatic melanoma characterized by the enrichment of metastasis-related pathways, intricate cell–cell communication, and heightened infiltration of pro-angiogenic tumor-associated macrophages compared to NMM. Importantly, patients in the high MET score group exhibited poorer prognoses and an immunosuppressive microenvironment, featuring increased infiltration of regulatory T cells and decreased infiltration of CD8+ T cells, compared to the low MET score patient group. Expression of PD-1 was markedly higher in patients with low MET scores. Anti-PD-1 (aPD-1) therapy profoundly affected antitumor immunity activation and metastasis inhibition in these patients. In summary, our study demonstrates the effectiveness of the MET score in predicting melanoma metastatic potential. For patients with low MET scores, aPD-1 therapy may be a potential treatment strategy to inhibit metastasis. Patients with high MET scores may benefit from combination therapies.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2058-7716
Relation: https://doaj.org/toc/2058-7716
DOI: 10.1038/s41420-023-01678-6
URL الوصول: https://doaj.org/article/c8d5e95afefb4072ae5616eadb823832
رقم الانضمام: edsdoj.8d5e95afefb4072ae5616eadb823832
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20587716
DOI:10.1038/s41420-023-01678-6